INSP240920P260000
- 79.70
- 0.000.00%
Inspire Medical Systems Newsroom
Leerink Partners Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Raises Target Price to $197
Inspire Medical Systems Is Maintained at Market Perform by Leerink Partners
Inspire Medical Systems Analyst Ratings
Lake Street Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $270
Lake Street Sticks to Their Buy Rating for Inspire Medical Systems (INSP)
Morgan Stanley Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $210
Buy Rating for Inspire Medical Systems Amid Positive Trends and Promising New Product Launch
Maintaining Hold on Inspire Medical Systems Amid Solid Q2 Performance and Cautious H2 Revenue Outlook
Inspire Medical Systems Price Target Cut to $200.00/Share From $220.00 by Baird
Inspire Medical Systems Analyst Ratings
Inspire Medical Systems: Hold Rating Amidst Strong Financials and Emerging Market Uncertainties
Analysts Offer Insights on Healthcare Companies: Inspire Medical Systems (INSP), Definitive Healthcare Corp (DH) and Bicycle Therapeutics (BCYC)
KeyBanc Remains a Buy on Inspire Medical Systems (INSP)
Lake Street Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $270
Maintaining Hold on Inspire Medical Systems Amid Policy Changes and Market Volatility
Lake Street Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $270
Inspire Medical Systems: Solid Q2 Performance Leads to Hold Rating Amid Balanced Risk/Reward
Lake Street Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $270
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Buy Rating
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Maintains Target Price $187